Tofacitinib Impurity

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com

Product Information

• Product Information

• Product Number: T006149

• English Name: Tofacitinib Impurity 149

• English Alias: 3-((3R,4R)-3-((7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

• CAS Number: 2407039-29-4

• Molecular Formula: C16H20N6O2

• Molecular Weight: 328.37

• Advantages: As a reference standard for Tofacitinib Impurity 149, it has an accurate chemical structure and high purity, with strict quality testing and identification. It has good stability and can maintain stable properties under different storage conditions and experimental environments. It can serve as a reliable reference substance, providing accurate evidence for the impurity detection of tofacitinib bulk drugs and formulations, ensuring the accuracy and repeatability of detection results, meeting the strict requirements of drug research, development, production, and quality supervision, and helping pharmaceutical companies and research institutions effectively control drug quality.

• Applications: It is mainly used in the quality research, impurity analysis, and quality control of tofacitinib bulk drugs and formulations. It is used to establish and validate impurity detection methods such as high-performance liquid chromatography (HPLC) and liquid chromatography - mass spectrometry (LC - MS). In the research and development process of tofacitinib, it is used to study the source and formation mechanism of this impurity, and optimize the synthesis process to reduce impurity generation. In the production process, it is used to monitor the content of Impurity 149 in products in real-time to ensure that drug quality meets relevant standards and regulatory requirements. It can also be used to evaluate the changes of impurities in tofacitinib drugs during storage and transportation, providing data support for drug stability research.

• Background Description: Tofacitinib is a drug used for the treatment of autoimmune diseases such as rheumatoid arthritis. In the process of its research and development and production, the presence of impurities may affect the safety, effectiveness, and stability of the drug. To ensure the safety of patients' medication and meet the requirements of drug regulation, strict research and precise control of impurities in tofacitinib are essential. As one of the impurities of tofacitinib, in-depth research on Tofacitinib Impurity 149 helps to improve the quality standard system of tofacitinib, enhance drug quality, and ensure the safety and effectiveness of clinical medication.

• Research Status: Currently, the research on Tofacitinib Impurity 149 mainly focuses on the optimization and improvement of impurity analysis methods. By using more advanced detection technologies and instruments, the sensitivity and accuracy of detecting this impurity are improved to achieve precise determination of trace impurities. At the same time, researchers are actively exploring the source and change rules of this impurity during the synthesis and storage of tofacitinib, and reducing the generation and accumulation of impurities by improving process conditions and optimizing the storage environment. In addition, the research on the potential impact of this impurity on the performance and safety of tofacitinib drugs is also gradually underway, aiming to provide a more comprehensive scientific basis for the overall evaluation of tofacitinib quality.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!